The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
GCLLSG 2016 | Overcoming mental health issues for patients with CLL
Arnon Kater, MD, PhD of the Academic Medical Center, Amsterdam, Netherlands talks about how to overcome mental health issues that may be seen within chronic lymphocytic leukemia (CLL) patients at the 2016 International Workshop of the German CLL Study Group (GCLLSG) in Cologne, Germany. Prof. Kater explains that when you deal with CLL, which you are never going to cure, considering the patients’ quality of life becomes very important. Although it is very challenging, clinicians must help patients understand that they shouldn’t be the disease but instead have the disease. In this way it is easier for the patient to live with the disease. Furthermore, it is easier for patients to do this with new drugs as the side effects are fewer and quality of life is improved.
